ArticleTargeted oncology2020

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis.

Ya Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.